NCT00473213View on ClinicalTrials.gov

Optimizing IFN Beta - 1B Dose

PHASE3CompletedINTERVENTIONAL

Enrollment

217

Participants

Timeline

Start Date

September 30, 1999

Study Completion Date

February 29, 2004

Conditions

Multiple Sclerosis

Interventions

DRUG

Interferon Beta 1

All Listed Sponsors

collaborator

Dimensione Ricerca s.r.l.

OTHER

lead

University of Turin, Italy

OTHER

NCT00473213 - Optimizing IFN Beta - 1B Dose | Biotech Hunter | Biotech Hunter